200 related articles for article (PubMed ID: 27826612)
1. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.
Toksoy A; Strifler S; Benoit S; Grigoleit GU; Knop S; Mielke S; Buder-Bakhaya K; Roth S; Goebeler M; Rosenwald A; Geissinger E; Wobser M
Acta Derm Venereol; 2017 Mar; 97(3):379-380. PubMed ID: 27826612
[No Abstract] [Full Text] [Related]
2. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador.
Montalvo N; Redrobán L
Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
4. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L
Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959
[TBL] [Abstract][Full Text] [Related]
5. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus.
Kim TH; Lee JH; Kim YC; Lee SE
J Cutan Pathol; 2015 Mar; 42(3):229-231. PubMed ID: 25488018
[No Abstract] [Full Text] [Related]
6. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
7. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
Plaza JA; Sangueza M
Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
9. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
10. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults.
Rodríguez-Pinilla SM; Barrionuevo C; Garcia J; Martínez MT; Pajares R; Montes-Moreno S; Casavilca S; Montes J; Bravo F; Zaharia M; Zevallos-Giampietri E; Sanchez L; Piris MA
Am J Surg Pathol; 2010 Dec; 34(12):1773-82. PubMed ID: 21107082
[TBL] [Abstract][Full Text] [Related]
11. Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma.
Lyapichev KA; Sukswai N; Wang XI; Khoury JD; Medeiros LJ
Am J Dermatopathol; 2020 Sep; 42(9):714-716. PubMed ID: 31313696
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
13. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.
Yin G; Ni Y; Xiao Z; He G; Miao K
Int J Clin Exp Pathol; 2015; 8(6):7588-93. PubMed ID: 26261674
[TBL] [Abstract][Full Text] [Related]
16. A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.
Fox CP; Haigh TA; Taylor GS; Long HM; Lee SP; Shannon-Lowe C; O'Connor S; Bollard CM; Iqbal J; Chan WC; Rickinson AB; Bell AI; Rowe M
Blood; 2010 Nov; 116(19):3695-704. PubMed ID: 20671118
[TBL] [Abstract][Full Text] [Related]
17. Extranodal NK/T-cell lymphoma, nasal type, possibly arising from chronic Epstein-Barr virus infection.
Seishima M; Yuge M; Kosugi H; Nagasaka T
Acta Derm Venereol; 2010; 90(1):102-3. PubMed ID: 20107744
[No Abstract] [Full Text] [Related]
18. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
Xie Y; Wang T; Wang L
J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
[TBL] [Abstract][Full Text] [Related]
19. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
[TBL] [Abstract][Full Text] [Related]
20. Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma.
Teo WL; Tan SY
J Clin Oncol; 2011 Apr; 29(12):e342-3. PubMed ID: 21282547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
